Familial clustering of ovarian and endometrial cancers

European Journal of Cancer

Volumn 40, Issue 1, 2004, Pages 90-95

  Hemminki, K ^a,b   Granstrom C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Endometrioid tumour; Familial risk; Seropapillary cystadenocarcinoma; Sibling risk

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE; HUMAN; INFANT; MATHEMATICAL COMPUTING; MOTHER; MULTIPLE MYELOMA; NEWBORN; OVARY CANCER; PRIORITY JOURNAL;

EID: 0346996533     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00627-0     Document Type: Article

References (45)

1. Center for Epidemiology. Cancer Incidence in Sweden 1998. Stockholm, The National Centre for Health and Welfare, 2000.
2. Hulka B. Epidemiologic analysis of breast and gynecologic cancers. Prog. Clin. Biol. Res. 396:1997;17-29.
3. Riman T., Persson I., Nilsson S. Hormonal aspects of epithelial ovarian cancer. review of epidemiological evidence Clin. Endocrinol. (Oxf.). 49:1998;695-707.
4. Henderson B., Feigelson H. Hormonal carcinogenesis. Carcinogenesis. 21:2000;427-433.
5. Kumar, V., Cotran, R., Robbins, S. Basic Pathology. Philadelphia, Saunders, 1997.
6. Ford D., Easton D., Stratton M.et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet. 62:1998;676-689.
7. Sutcliffe S., Pharoah P.D., Easton D.F., Ponder B.A. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer. Int. J. Cancer. 87:2000;110-117.
8. Risch H.A., McLaughlin J.R., Cole D.E.et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am. J. Hum. Genet. 68:2001;700-710.
9. Narod S.A., Boyd J. Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr. Opin. Obstet. Gynecol. 14:2002;19-26.
10. Werness B.A., Parvatiyar P., Ramus S.J.et al. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. J. Natl. Cancer Inst. 92:2000;1088-1091.
11. Casey M.J., Bewtra C., Hoehne L.L., Tatpati A.D., Lynch H.T., Watson P. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. Gynecol. Oncol. 78:2000;278-287.
12. Watson P., Butzow R., Lynch H.T.et al. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol. Oncol. 82:2001;223-228.
13. Aarnio M., Sankila R., Pukkala E.et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int. J. Cancer. 81:1999;214-218.
14. Wijnen J., de Leeuw W., Vasen H.et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat. Genet. 23:1999;142-144.
15. Zhou X.P., Kuismanen S., Nystrom-Lahti M., Peltomaki P., Eng C. Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumours. Hum. Mol. Genet. 11:2002;445-450.
16. Risinger J., Haayes A., Berchuck A., Barrett J. PTEN/MMAC1 Mutations in endometrial cancer. Cancer Res. 57:1997;4736-4738.
17. Mutter G.L., Lin M.C., Fitzgerald J.T.et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl. Cancer Inst. 92:2000;924-930.
18. Parazzini F., Negri E., La Vecchia C., Restelli C., Franceschi S. Family history of reproductive cancers and ovarian cancer risk. an Italian case-control study Am. J. Epidemiol. 135:1992;35-40.
19. Narod S.A., Madlensky L., Bradley L.et al. Hereditary and familial ovarian cancer in southern Ontario. Cancer. 74:1994;2341-2346.
20. Goldgar D.E., Easton D.F., Cannon-Albright L.A., Skolnick M.H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl. Cancer Inst. 86:1994;1600-1607.
21. Gruber S., Thompson W. The CaSH Study. A population-based study of endometrial cancer and familial risk in younger women. Cancer Epidemiol. Biomarkers Prev. 5:1996;411-417.
22. Easton D., Matthews F., Ford D., Swerdlow A., Peto J. Cancer mortality in relatives of women with ovarian cancer. the OPCS study Int. J. Cancer. 65:1996;284-294.
23. Auranen A., Grenman S., Makinen J., Pukkala E., Sankila R., Salmi T. Borderline ovarian tumours in Finland. epidemiology and familial occurrence Am. J. Epidemiol. 144:1996;548-553.
24. Auranen A., Pukkala E., Makinen J., Sankila R., Grenman S., Salmi T. Cancer incidence in the first-degree relatives of ovarian cancer patients. Br. J. Cancer. 74:1996;280-284.
25. Hemminki K., Vaittinen P. Familial cancers in a nation-wide family-cancer database. age distribution and prevalence Eur. J. Cancer. 35:1999;1109-1111.
26. Hemminki K., Vaittinen P., Dong C. Endometrial cancer in the Family-Cancer Database. Cancer Epidemiol. Biomarkers Prev. 8:1999;1005-1010.
27. Stratton J., Thompson D., Bobrow L.et al. The genetic epidemiology of early-onset epithelial ovarian cancer. a population-based study Am. J. Hum. Genet. 65:1999;1725-1732.
28. Anderson H., Bladstrom A., Olsson H., Moller T.R. Familial breast and ovarian cancer. a Swedish population-based register study Am. J. Epidemiol. 152:2000;1154-1163.
29. Dong C., Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int. J. Cancer. 91:2001;144-150.
30. Hemminki K., Li X., Plna K., Granström C., Vaittinen P. The nation-wide Swedish Family-Cancer Database. updated structure and familial rates Acta Oncol. 40:2001;772-777.
31. Hemminki K. Genetic epidemiology. science and ethics on familial cancers Acta Oncol. 40:2001;439-444.
32. Hemminki K., Li X. Familial carcinoid tumours and subsequent cancers. a nation-wide epidemiological study from Sweden Int. J. Cancer. 94:2001;444-448.
33. Hemminki K., Vaittinen P., Dong C., Easton D. Sibling risks in cancer. clues to recessive or X-linked genes? Br. J. Cancer. 84:2001;388-391.
34. Hemminki K., Li X. Familial risk of cancer by site and histopathology. Int. J. Cancer. 103:2003;105-109.
35. Holschneider C.H., Berek J.S. Ovarian cancer. epidemiology, biology, and prognostic factors Semin. Surg. Oncol. 19:2000;3-10.
36. Jaffe E., Harris N., Stein H., Vardiman J. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. 2001;IARC, Lyon.
37. Lynch H., Sanger W., Pirruccello S., Quinn-Laquer B., Weisenburger D. Familial multiple myeloma. a family study and review of the literature J. Natl. Cancer Inst. 93:2001;1479-1483.
38. Hemminki K. Re: Familial multiple myeloma: a family study and review of the literature. J. Natl. Cancer Inst. 94:2002;462-463.
39. Herrinton L.J., Voigt L.F., Weiss N.S., Beresford S.A., Wingo P.A. Risk factors for synchronous primary endometrial and ovarian cancers. Ann. Epidemiol. 11:2001;529-533.
40. Zaino R., Whitney C., Brady M.F., DeGeest K., Burger R.A., Buller R.E. Simultaneously detected endometrial and ovarian carcinomas - a prospective clinicopathologic study of 74 cases. a gynecologic oncology group study Gynecol. Oncol. 83:2001;355-362.
41. Hemminki K, Aaltonen L, Li X. Subsequent primary cancers after endometrial and ovarian cancer. Cancer 2003, 97, 2432-2439.
42. Thompson D., Easton D.F. Cancer Incidence in BRCA1 mutation carriers. J. Natl. Cancer Inst. 94:2002;1358-1365.
43. Lynch H., de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J. Med. Genet. 36:1999;801-818.
44. Wagner A., Hendriks Y., Meijers-Heijboer E.J.et al. Atypical HNPCC owing to MSH6 germline mutations. analysis of a large Dutch pedigree J. Med. Genet. 38:2001;318-322.
45. Hemminki A., Markie D., Tomlinson I.et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 391:1998;184-187.